ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Funding Opportunities Listed.

January 21, 2005

In Congress: HHS Hasn’t Identified Another Source For NIH Increase If Tobacco Bill Not Passed: Shalala

March 6, 1998

NCI Breast Tissue Registry Available To Researchers

March 24, 1995